View Document Preview and Link Document Date: 2014-10-14 16:30:23 Open Document File Size: 611,22 KB Share Result on Facebook
City Reference / / Company TOLMAR Pharmaceuticals Inc. / / Facility Laboratory Test Interactions / Laboratory Tests Response / / IndustryTerm gray rubber cap / treatment of advanced prostate cancer / Monitor for cardiovascular disease / injection site / treatment for patients with prostate cancer / mixed product / / MedicalCondition ureteral obstruction / Tumor / paralysis / advanced prostate cancer / pituitary apoplexy / sudden cardiac death / Hypersensitivity ELIGARD / hematuria / Carcinogenesis / Hyperglycemia / bladder outlet obstruction / cardiovascular disease / diabetes / Known hypersensitivity / pain / fatigue / myocardial infarction / diabetes mellitus / spinal cord compression / Anaphylactic reactions / Hypersensitivity / prostate cancer / Cardiovascular diseases / Diabetes Hyperglycemia / / MedicalTreatment Counseling / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Product leuprolide acetate / testosterone / ELIGARD / Injectable suspension / / Technology Pharmacokinetics / diagnostic tests / Pharmacodynamics / / URL www.fda.gov/medwatch / / SocialTag 
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIGARD safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) suspensio